5-Amino-1MQ
Fat LossSmall Molecule / MetabolicExperimental
Small-molecule NNMT inhibitor marketed as 5-Amino-1MQ for metabolic research; supports NAD+ elevation and fat oxidation.
For research use only.
Key Facts
- CAS
- 42464-96-0
- Molecular Weight (MW)
- 286.11 g/mol
- Half-life
- 3.8-6.9 hours
- Unit
- mg
- Administration Route
- Oral
- Frequency
- 1-3x daily
- Last updated
- 12/14/2025
- Targets
- NNMT enzymeNAD+ pathways
Overview
Small-molecule NNMT inhibitor marketed as 5-Amino-1MQ for metabolic research; supports NAD+ elevation and fat oxidation.
Protocol
- Dosage Range
- 50-150 mg per day, split doses
- Frequency
- 1-3x daily
- Cycle
- 4-12 weeks on, 4 weeks off
- Administration Route
- Oral
- Reconstitution Guide
- N/A (capsule form common)
Science
Mechanism of Action
Inhibits NNMT to elevate NAD+, enhance fat oxidation, improve insulin sensitivity.
Targets
NNMT enzymeNAD+ pathways
Studies
- — Journal/year not available
- — Journal/year not available
Benefits
Fat loss supportImproved metabolic efficiencyEnhanced energy and staminaBetter insulin sensitivityMitochondrial optimizationAnti-aging cellular effects
Potential Side Effects
- Mild gastrointestinal upset
- Headache
- Fatigue (rare)